Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Athira Pharma Inc (ATHA)

NASDAQ
Currency in USD
Disclaimer
1.920
0.000(0.00%)
Closed
After Hours
1.900-0.020(-1.042%)

ATHA Comments

buena subida hoy
Athira Pharma: Fosgonimeton può superare Lecanemab nell'Alzheimer20 ottobre 2022 7:36 AM ETAthira Pharma, Inc. (ATHA)ESALY2 Il titolo di Athira Pharma è stato venduto alcuni mesi fa a causa del mancato raggiungimento dell'endpoint primario in uno studio randomizzato di Fase 2 da parte del suo candidato farmaco per l'Alzheimer, il Fosgonimeton.Il braccio di monoterapia ha mostrato un'efficacia notevole, che sembra più forte del 27% di rallentamento del declino cognitivo.Recenti rapporti hanno dimostrato che Fosgonimeton è potenzialmente modificante della malattia, contrariamente agli standard di cura esistenti.Lo studio di fase 2/3, potenzialmente cruciale, è stato ora ottimizzato per concentrarsi sulla monoterapia con Fosgonimeton e dovrebbe concludersi a metà del 2023.La capitalizzazione di mercato di 128 milioni di dollari di Athira Pharma corrisponde alla metà della sua liquidità, che dovrebbe essere ampiamente sufficiente fino alla lettura del topline della Fase 2/3 all'inizio del 2024.
https://www.tipranks.com/stocks/atha/forecast
Athira Pharma Advances Phase 2/3 LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients Following Independent, Unblinded Interim Analysis
Hope to see 20$ arround soon
me too
I hope it's higher than that.
11
Bought the huge Dip. Wonder what it will end up today.
ATHA Insider Trading Activity (Athira Pharma) | MarketBeat
Athira Pharma Perceptive Advisors Llc  Director Buy 311,111 shares @ $22.50 $6,999,997.50 1/25/2021 $21.45
somebody bought a big volume of shares is this a signal please ? any body hereeeee?
This keeps moving up quietly
I like the fact that there's almost no-one on here talking about this company.....
looking forward to earn someee Others?/
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.